A Study of Abemaciclib in Participants With Cancer That is Advanced or Has Spread to Another Part(s) of the Body
Clinical trial NCT02688088 · COMPLETED
Trial details
- NCT number
- NCT02688088
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-08
- Primary completion
- 2018-02-04
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.